Leukotriene A4
Top View
- The Role of Leukotrienes As Potential Therapeutic Targets in Allergic Disorders
- Metabolism of Leukotriene A4 by an Enzyme in Blood Plasma
- Leukotriene C 4 Modulation of Muscarinic K + Current Activation in Bullfrog Atrial Myocytes
- LTA4H Association with Montelukast Response in Early and Late-Onset
- [0.95]Arachidonic Acid Metabolism and Kidney Inflammation
- Targeting Mammalian 5-Lipoxygenase by Dietary Phenolics As an Anti-Inflammatory Mechanism: a Systematic Review
- Leukotriene Receptor Antagonists and Biosynthesis Inhibitors: Potential Breakthrough in Asthma Therapy
- Phase 2 Trial of Montelukast for Prevention of Pain in Sickle Cell Disease
- For Extracellular Leukotriene A4 (Leukotrienes/Arachidonic Acid/Lipoxygenase/Neutrophils/Cellular Interactions) CLEMENS A
- Leukotriene A4 Hydrolase in Human Bronchoalveolar Lavage Fluid
- The Role of Montelukast in Traumatic Brain Injury and Brain Ischemia
- Leukotriene Antagonism in Asthma and Rhinitis
- Leukotriene A4 Hydrolase – an Evolving Therapeutic Target
- Leukotriene B4 Receptor Antagonist LY293111 Inhibits Proliferation and Induces Apoptosis in Human Pancreatic Cancer Cells1